The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in February 2019.
Launching on World Parkinson's Day is attention-grabbing marketing campaign 'Parkinson's Is'. Wesley Vernon shares how people affected by Parkinson's have shaped the campaign.
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Anna Carapellotti and researchers from the School of Psychology at Queen's University Belfast (QUB) are conducting a study evaluating the immediate effects of dance in people with Parkinson's.